Jason Brown
Founder and President
- Brown Pharma Consulting, Ltd.
Jason Brown is the Founder and President of Brown Pharma Consulting, Ltd., where he brings end-to-end expertise in impurity control strategies, risk-based frameworks, and long-term stability assurance to regulatory, quality, and technical teams worldwide. His work in nitrosamine risk management — encompassing root cause analysis, structural identification, reformulation, and control strategy development — exemplifies the science-driven, release-to-shelf-life thinking that underpins robust stability programs. Jason is the author of the July 2025 AAPS Newsmagazine Cover Article, “Nitrosamine Control Strategies: From Risk Identification to Implementation,” and holds a patent application for innovative inhibition techniques, with additional research contributions on environmental factors and gastric nitrosamine formation. He can be reached at brownpharmaconsulting@outlook.